These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4426649)

  • 1. Studies in fluorinated Mannich bases: Part I--Syntheses & biological activity of some new 3-alkyl amino propiophenones.
    Joshi KC; Pathak VN; Singh R
    Indian J Exp Biol; 1974 Jan; 12(1):46-8. PubMed ID: 4426649
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies in fluorinated Mannich bases. Part 2: Synthesis and biological activity of some new 3-alkylaminopropiophenones.
    Pathak VN; Singh RP
    Pharmazie; 1980; 35(7):434. PubMed ID: 7413714
    [No Abstract]   [Full Text] [Related]  

  • 3. [New cardioactive beta-aminoketones. Synthesis and considerations on the relationships between pharmacologic effect and constitution of new Mannich bases. I].
    Thiele K; Schimassek U; von Schlichtegroll A
    Arzneimittelforschung; 1966 Aug; 16(8):1064-7. PubMed ID: 6014891
    [No Abstract]   [Full Text] [Related]  

  • 4. [Secondary depressive effect of propafenon on the low electric activity in isolated rabbit heart].
    Barbosa HL; de Carvalho AP
    Arq Bras Cardiol; 1979 Dec; 33(6):459-62. PubMed ID: 550785
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemodynamic effects of oxyfedrine].
    Sorrentino F; Mistretta A; Andreozzi GM; Cottini E; Grimaldi DR; Signorelli S
    Boll Soc Ital Cardiol; 1975; 20(10):1213-7. PubMed ID: 1234421
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of oxyfedrine on the blood flow of coronary vessels in intra- and extramural regions (studies on the dog)].
    Düx A; Hahn N; Felix R; Draznin N; Meuser HJ
    Arzneimittelforschung; 1969 Mar; 19(3):300-4. PubMed ID: 5818776
    [No Abstract]   [Full Text] [Related]  

  • 7. Highly enantioselective synthesis of fluorinated gamma-amino alcohols through proline-catalyzed cross-Mannich reaction.
    Fustero S; Jiménez D; Sanz-Cervera JF; Sánchez-Roselló M; Esteban E; Simón-Fuentes A
    Org Lett; 2005 Aug; 7(16):3433-6. PubMed ID: 16048310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological and toxicological studies on the effect characterization of etafenone].
    Hapke HJ; Sterner W
    Arzneimittelforschung; 1969 Oct; 19(10):1664-72. PubMed ID: 5395365
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-arrhythmic property of a derivative of propiophenone].
    Duteil J; Cheymol G; Olive G
    Med Pharmacol Exp Int J Exp Med; 1967; 17(3):231-8. PubMed ID: 5631089
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action of oxyphedrin on the coronary circulation studied by dye dilution curves].
    Barbosa J; Lopes AS; Lopes JS; Veloso LF; Benchimol AB
    Arq Bras Cardiol; 1973 Apr; 26(2):161-5. PubMed ID: 4581415
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of propafenon on sinus node function].
    Sant'Anna JR; Belardinelli L; Lucchese FA
    Arq Bras Cardiol; 1980 Jul; 35(1):15-8. PubMed ID: 7224885
    [No Abstract]   [Full Text] [Related]  

  • 12. [Behavior of myocardial contractions in chronic coronary insufficiency and under the effects of oxyphedrine].
    Ferreira Montero I; González Carretero M; Del Rio Ligorit A; La Figuera Benito E
    Rev Esp Cardiol; 1974; 27(5):391-9. PubMed ID: 4456468
    [No Abstract]   [Full Text] [Related]  

  • 13. [Stimulation of adrenergic beta-receptors in the heart of normal and reserpinized guinea pigs by oxyfedrine].
    Kukovetz WR; Pöch G
    Arzneimittelforschung; 1969 Sep; 19(9):1562-6. PubMed ID: 5394533
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of propafenon on the electric activity of the rabbit heart "in vitro"].
    de Carvalho AP; de Saldenã LS; Cukierman S
    Arq Bras Cardiol; 1979 Nov; 33(5):383-9. PubMed ID: 550773
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological studies on ticlopidine, a new platelet aggregation inhibitor. Part I: Cardiovascular effects.
    Akashi A; Tamura K; Hirohashi M; Watanabe K; Kasahara A
    Arzneimittelforschung; 1980; 30(3):409-14. PubMed ID: 7387750
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-induced changes in blood flow in normal and ischaemic regions of the canine myocardium.
    Ledingham IM; Marshall RJ; Parratt JR
    Br J Pharmacol; 1973 Mar; 47(3):626P-627P. PubMed ID: 4730845
    [No Abstract]   [Full Text] [Related]  

  • 17. Glucagon: its mechanism of action on the coronary circulation in the conscious dog.
    Terry B; White FC; Bloor CM
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):383-9. PubMed ID: 5074531
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of the partial beta-adrenergic receptor agonist, oxyfedrine, on regional myocardial blood flow and left ventricular function in patients with coronary artery disease].
    Dirschinger J; Fleck E; Rudolph W
    Herz; 1982 Dec; 7(6):351-7. PubMed ID: 7160821
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on blood circulation after and without administration of oxyfedrine in altitudes of 600 and 2,200m].
    Raas E; Schnopfhagen H; Meirer R; Knapp E; Aigner A
    Arzneimittelforschung; 1971 Mar; 21(3):349-53. PubMed ID: 5107969
    [No Abstract]   [Full Text] [Related]  

  • 20. [Glucagon: effects on hemodynamics and myocardial metabolism].
    Moret P; Duchosal F; Steinmann JM
    Arch Mal Coeur Vaiss; 1972 Aug; 65(8):971-9. PubMed ID: 4633640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.